942077-16-9

Basic information

• Product Name: 3-Cyano-5-(trifluoroMethyl)benzoic Acid
• Synonyms: 3-Cyano-5-(trifluoroMethyl)benzoic Acid
• CAS NO: 942077-16-9
• Molecular Formula: C₉H₄F₃NO₂
• Molecular Weight: 215.1287696
• Mol File: 942077-16-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 308.7±42.0 °C(Predicted)
• Appearance: /
• Density: 1.50±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 3.21±0.10(Predicted)
• CAS DataBase Reference: 3-Cyano-5-(trifluoroMethyl)benzoic Acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Cyano-5-(trifluoroMethyl)benzoic Acid(942077-16-9)
• EPA Substance Registry System: 3-Cyano-5-(trifluoroMethyl)benzoic Acid(942077-16-9)

Safety Data

• Hazardous Substances Data: 942077-16-9(Hazardous Substances Data)

Usage

General Description

3-Cyano-5-(trifluoroMethyl)benzoic Acid is a chemical compound with the molecular formula C10H5F3N2O2. It is a white solid that is soluble in organic solvents and is used in the synthesis of pharmaceuticals and agrochemicals. It is also a building block for the production of various other chemicals. The chemical structure of 3-Cyano-5-(trifluoroMethyl)benzoic Acid contains a cyano group, a trifluoromethyl group, and a benzoic acid group, making it a versatile compound for various applications in the chemical industry.

Upstream product

• 942077-15-8 3-cyano-5-trifluoromethyl-benzoic acid methyl ester 
• 557-21-1 zinc(II) cyanide 
• 328-67-6 3-bromo-5-(trifluoromethyl)benzoic acid 
• 569370-38-3 3-(hydroxymethyl)-5-(trifluoromethyl)benzonitrile 

Downstream Products

• 1057667-29-4 3-cyano-N-methoxy-N-methyl-5-(trifluoromethyl)benzamide 
• 1333152-56-9 (Z)-isopropyl 3-(3-(3-cyano-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate 
• 1369925-74-5 3-cyano-5-(trifluoromethyl)benzamide 
• 1388842-28-1 3-carbamothioyl-5-(trifluoromethyl)benzamide 
• 1388842-29-2 3-(1H-1,2,4-triazol-3-yl)-5-(trifluoromethyl)benzamide 
• 1388842-31-6 3-(1H-1,2,4-triazol-3-yl)-5-(trifluoromethyl)benzonitrile 
• 1388842-32-7 (Z)-3-(3-(3-cyano-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid 
• 1388842-33-8 (Z)-3-(3-(3-cyano-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic (isobutyl carbonic) anhydride 
• 1388842-34-9 (Z)-3-(3-(3-cyano-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylohydrazide 
• 1388841-51-7 (Z)-3-(1-(2-(1,3,4-oxadiazol-2-yl)vinyl)-1H-1,2,4-triazol-3-yl)-5-(trifluoromethyl)benzonitrile 
• 1029317-37-0 3-cyano-5-(trifluoromethyl)benzoyl chloride 
• 1057667-30-7 3-acetyl-5-(trifluoromethyl)benzonitrile 

Relevant articles and documents

Substituted phenylimidazopyrazoles and their use

The present application relates to novel 1-phenyl-1H-imidazo[1,2-b]pyrazole derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular angiogenic disorders and hyperproliferative disorders, where neovascularization plays a role, such as, for example, neoplastic disorders and tumour disorders. Such treatments can be carried out as monotherapy or else in combination with other medicaments or further therapeutic measures.

3-AMINO-PYRIDINES AS GPBAR1 AGONISTS

This invention relates to novel 3-aminopyridines of the formula (I) wherein B1, B2 and R1 to R6 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.

NOVEL PYRIMIDINE COMPOUNDS HAVING BENZYL (HETEROCYCLIC METHYL) AMINE STRUCTURE AND MEDICAMENT COMPRISING THE SAME

A compound represented by the following general formula (I), wherein R1, R2, R3, R4 and R5 represent hydrogen atom, a halogen atom, a lower alkyl group and the like, R6 represents an alkyl group, a cycloalkyl group and the like, R7 and R8 represent hydrogen atom, a lower alkyl group, a (lower cycloalkyl)(lower alkyl) group and the like, R9 represents hydrogen atom, a halogen atom, a lower alkoxy group and the like, R10 and R11 represent hydrogen atom, a lower alkyl group, a lower alkoxy group, a halo(lower alkyl) group and the like, and A represents a heterocyclic ring constituted by 6 to 10 atoms, which has potent inhibitory activity on cholesterol ester transfer protein (CETP).